News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
137 Results
Type
Article (31)
Press Release (106)
Section
Business (42)
Deals (7)
Drug Development (54)
FDA (1)
News (78)
Policy (2)
Tag
Academia (1)
Alliances (18)
Antibody-drug conjugate (ADC) (7)
Approvals (1)
Cancer (5)
Clinical research (39)
Collaboration (1)
COVID-19 (4)
C-suite (2)
Data (3)
Earnings (4)
Events (29)
FDA (5)
GLP-1 (1)
Healthcare (2)
Infectious disease (4)
IPO (3)
Mergers & acquisitions (4)
NextGen: Class of 2026 (1)
Non-profit (3)
Patient recruitment (1)
People (16)
Phase 1 (24)
Phase 2 (25)
Phase 3 (9)
Pipeline (1)
Postmarket research (1)
Preclinical (8)
Real estate (1)
Regulatory (6)
Research institute (3)
Startups (1)
Vaccines (1)
Date
Last 30 days (1)
Last 365 days (6)
2026 (6)
2025 (10)
2024 (7)
2023 (6)
2022 (21)
2021 (19)
2020 (23)
2019 (20)
2018 (9)
2017 (7)
2016 (3)
2015 (1)
2014 (3)
2013 (1)
2012 (1)
Location
Africa (1)
Asia (18)
Australia (4)
China (2)
Europe (91)
Massachusetts (14)
United States (14)
137 Results for "sotio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
FDA Grants Fast Track Designation to SOTIO’s SOT106 ADC for Soft Tissue Sarcoma Treatment, Accelerating Clinical Development
August 26, 2026
·
3 min read
Press Releases
SOTIO Presents Initial Data from VICTORIA-01 Phase 1 Clinical Study of Immunocytokine SOT201 at SITC Annual Meeting
November 6, 2026
·
3 min read
Press Releases
FDA Grants Fast Track Designation to SOTIO’s SOT109, a CDH17-targeting ADC for Colorectal Cancer
July 14, 2026
·
2 min read
Press Releases
SOTIO Advances SOT106 with Dual FDA Designations, Further Positioning the Program as a Potential Best-in-Class ADC for Sarcoma
September 23, 2026
·
3 min read
Press Releases
SOTIO Doses First Patient in Phase 1/2 CADENCIA-01 Clinical Trial of SOT109, a CDH17-Targeting ADC for Colorectal Cancer
September 9, 2026
·
4 min read
Press Releases
SOTIO Receives U.S. FDA Orphan Drug Designation for SOT106, a Potential Best-in-Class ADC for Sarcoma
June 3, 2026
·
3 min read
Press Releases
SOTIO Announces Promotion of Vivi Boura to Chief Medical Officer
November 3, 2025
·
2 min read
Press Releases
SOTIO to Present Data Highlighting Progress Across ADC and Immunocytokine Programs at Upcoming Scientific Conferences
October 31, 2025
·
3 min read
Press Releases
SOTIO Presents Positive Results from Non-Human Primate Study of SOT106, a Potential Best-in-Class ADC for Treatment of Sarcoma
November 13, 2025
·
3 min read
Press Releases
SOTIO Strengthens Leadership Team with Appointments of Amy Jensen-Smith as Chief Scientific Officer and Ulrich Moebius as Chief Development Officer
October 3, 2025
·
3 min read
1 of 14
Next